Form 4 · Filed Jun 3, 2026, 11:24 PM UTC
CORT/CORCEPT THERAPEUTICS INC
Guyer William — Chief Development Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | A | other | 877 | $70 | $61,776 | 3,108 |
| Jun 1, 2026 | A | other | 877 | $0 | $0 | 3,985 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-256015